Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.
Writing in NEJM, Columbia ophthalmologists say a form of Vitamin B3 may be able to stop the progression of glaucoma by protecting the eye's neurons.
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
Columbia University researchers slowed vision loss in mice who have a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.
Eye damage from high-power lasers can masquerade as genetic eye diseases and lead to costly work-ups, Columbia ophthalmologists find.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.